Published in J Gastroenterol on December 04, 2012
Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol (2015) 1.00
Progress and opportunities in molecular pathological epidemiology of colorectal premalignant lesions. Am J Gastroenterol (2014) 0.98
Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96
Genetic predisposition to colorectal cancer: where we stand and future perspectives. World J Gastroenterol (2014) 0.90
Contrast coating for the surface of flat polyps at CT colonography: a marker for detection. Eur Radiol (2014) 0.89
Prevalence and risk factors of asymptomatic colorectal polyps in taiwan. Gastroenterol Res Pract (2014) 0.80
IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. World J Gastroenterol (2014) 0.80
Smoking status informs about the risk of advanced serrated polyps in a screening population. Endosc Int Open (2015) 0.79
Multiple primary colorectal cancer: Individual or familial predisposition? World J Gastrointest Oncol (2015) 0.78
The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway. Oncotarget (2016) 0.78
Assessment of colorectal polyp recognition skill: development and validation of an objective test. Surg Endosc (2016) 0.78
MicroRNA-31 expression in colorectal serrated pathway progression. World J Gastroenterol (2014) 0.77
SMO expression in colorectal cancer: associations with clinical, pathological, and molecular features. Ann Surg Oncol (2014) 0.77
Histology subtypes and polyp size are associated with synchronous colorectal carcinoma of colorectal serrated polyps: a study of 499 serrated polyps. Am J Cancer Res (2014) 0.77
CT-Colonography vs. Colonoscopy for Detection of High-Risk Sessile Serrated Polyps. Am J Gastroenterol (2016) 0.76
Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp. Can J Gastroenterol Hepatol (2017) 0.75
Patient age and duration of colonoscopy are predictors for adenoma detection in both proximal and distal colon. World J Gastroenterol (2015) 0.75
Serrated polyposis associated with a family history of colorectal cancer and/or polyps: The preferential location of polyps in the colon and rectum defines two molecular entities. Int J Mol Med (2016) 0.75
Impact of reassessment of colonic hyperplastic polyps by expert GI pathologists. Int J Colorectal Dis (2016) 0.75
The CpG island methylator phenotype is concordant between primary colorectal carcinoma and matched distant metastases. Clin Epigenetics (2017) 0.75
Epidemiology of Colorectal Adenomas and Histopathological Assessment of Endoscopic Specimens in the Colorectum. Viszeralmedizin (2014) 0.75
Role of Fusobacteria in the serrated pathway of colorectal carcinogenesis. Sci Rep (2016) 0.75
Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article. Medicine (Baltimore) (2016) 0.75
Absence of the Epithelial Glycocalyx As Potential Tumor Marker for the Early Detection of Colorectal Cancer. PLoS One (2016) 0.75
KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia. PLoS One (2017) 0.75
Systematic Review with Meta-Analysis: Alcohol Consumption and Risk of Colorectal Serrated Polyp. Dig Dis Sci (2015) 0.75
Pathological features of the sessile serrated adenoma/polyp with special references of its carcinogenesis. Med Mol Morphol (2014) 0.75
Serrated Polyps of Colon and Rectum: a Clinicopathologic Review. J Gastrointest Cancer (2017) 0.75
Comprehensive molecular characterization of human colon and rectal cancer. Nature (2012) 34.13
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Association of colonoscopy and death from colorectal cancer. Ann Intern Med (2008) 15.51
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature (2002) 7.46
Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology (2007) 7.16
Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell (2008) 6.84
Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med (2011) 6.50
Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst (2009) 6.21
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology (2012) 4.13
BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut (2004) 4.06
Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut (2010) 4.01
Analysis of administrative data finds endoscopist quality measures associated with postcolonoscopy colorectal cancer. Gastroenterology (2010) 3.91
The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology (2010) 3.87
Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol (2003) 3.59
Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut (2009) 3.34
Serrated polyps of the large intestine: a morphologic and molecular review of an evolving concept. Am J Clin Pathol (2005) 3.29
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24
Polyps and cancer of the large bowel: a necropsy study in Liverpool. Gut (1982) 3.23
Endoscopic mucosal resection outcomes and prediction of submucosal cancer from advanced colonic mucosal neoplasia. Gastroenterology (2011) 3.13
Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst (2006) 3.08
Hyperplastic-like colon polyps that preceded microsatellite-unstable adenocarcinomas. Am J Clin Pathol (2003) 3.05
Rate and predictors of early/missed colorectal cancers after colonoscopy in Manitoba: a population-based study. Am J Gastroenterol (2010) 2.97
Update on the serrated pathway to colorectal carcinoma. Hum Pathol (2010) 2.78
Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol (2006) 2.55
Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol (2011) 2.53
High-definition chromocolonoscopy vs. high-definition white light colonoscopy for average-risk colorectal cancer screening. Am J Gastroenterol (2010) 2.47
Variation in the detection of serrated polyps in an average risk colorectal cancer screening cohort. Am J Gastroenterol (2010) 2.44
Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol (2010) 2.34
Sessile serrated adenoma (SSA) vs. traditional serrated adenoma (TSA). Am J Surg Pathol (2008) 2.30
Miss rate of right-sided colon examination during colonoscopy defined by retroflexion: an observational study. Gastrointest Endosc (2011) 2.27
Sessile serrated adenomas: prevalence of dysplasia and carcinoma in 2139 patients. J Clin Pathol (2010) 2.26
Microsatellite instability in interval colon cancers. Gastroenterology (2006) 2.23
CIMP status of interval colon cancers: another piece to the puzzle. Am J Gastroenterol (2009) 2.17
Validation of a simple classification system for endoscopic diagnosis of small colorectal polyps using narrow-band imaging. Gastroenterology (2012) 2.11
A novel pit pattern identifies the precursor of colorectal cancer derived from sessile serrated adenoma. Am J Gastroenterol (2012) 2.06
Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol (2005) 2.03
Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology (2010) 1.95
Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut (2010) 1.94
Cancer risks for relatives of patients with serrated polyposis. Am J Gastroenterol (2012) 1.88
Cap-fitted colonoscopy: a randomized, tandem colonoscopy study of adenoma miss rates. Gastrointest Endosc (2010) 1.87
Polyps of the large intestine in Aarhus, Denmark. An autopsy study. Scand J Gastroenterol (1989) 1.79
The presence of large serrated polyps increases risk for colorectal cancer. Gastroenterology (2010) 1.73
How many molecular subtypes? Implications of the unique tumor principle in personalized medicine. Expert Rev Mol Diagn (2012) 1.66
Pathological reassessment of hyperplastic colon polyps in a city-wide pathology practice: implications for polyp surveillance recommendations. Gastrointest Endosc (2012) 1.60
Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res (2007) 1.56
DNA methylation within the normal colorectal mucosa is associated with pathway-specific predisposition to cancer. Oncogene (2009) 1.53
Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol (2009) 1.47
Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev (2008) 1.36
Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". Am J Clin Pathol (2006) 1.36
V600EBraf induces gastrointestinal crypt senescence and promotes tumour progression through enhanced CpG methylation of p16INK4a. EMBO Mol Med (2010) 1.36
Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One (2010) 1.36
Sessile serrated adenoma: challenging discrimination from other serrated colonic polyps. Am J Surg Pathol (2008) 1.35
Longitudinal outcome study of sessile serrated adenomas of the colorectum: an increased risk for subsequent right-sided colorectal carcinoma. Am J Surg Pathol (2010) 1.33
Molecular characteristics of serrated adenomas of the colorectum. Gut (2002) 1.31
High definition colonoscopy vs. standard video endoscopy for the detection of colonic polyps: a meta-analysis. Endoscopy (2011) 1.30
Promoter methylation of the mutated in colorectal cancer gene is a frequent early event in colorectal cancer. Oncogene (2007) 1.28
Meta-analysis of narrow-band imaging versus conventional colonoscopy for adenoma detection. Gastrointest Endosc (2012) 1.28
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27
Pancolonic chromoendoscopy with indigo carmine versus standard colonoscopy for detection of neoplastic lesions: a randomised two-centre trial. Gut (2010) 1.26
Molecular features of colorectal hyperplastic polyps and sessile serrated adenoma/polyps from Korea. Am J Surg Pathol (2011) 1.23
A morphologic analysis of sessile serrated polyps observed during routine colonoscopy (with video). Gastrointest Endosc (2011) 1.22
Risk factors for sessile serrated adenomas. J Clin Gastroenterol (2011) 1.22
Surveillance guidelines should be updated to recognize the importance of serrated polyps. Gastroenterology (2010) 1.21
Colorectal endoscopy, advanced adenomas, and sessile serrated polyps: implications for proximal colon cancer. Am J Gastroenterol (2012) 1.21
Sessile serrated adenoma with early neoplastic progression: a clinicopathologic and molecular study. Am J Surg Pathol (2011) 1.21
Progression of a sessile serrated adenoma to an early invasive cancer within 8 months. Dig Dis Sci (2008) 1.20
Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. Mod Pathol (2011) 1.20
The intestine-specific transcription factor Cdx2 inhibits beta-catenin/TCF transcriptional activity by disrupting the beta-catenin-TCF protein complex. Carcinogenesis (2009) 1.16
Serrated polyps of the colorectum: is sessile serrated adenoma distinguishable from hyperplastic polyp in a daily practice? Virchows Arch (2007) 1.15
KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol (2010) 1.15
Colonoscopy and diminutive polyps: hot or cold biopsy or snare? Do I send to pathology? Clin Gastroenterol Hepatol (2010) 1.13
Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation. Am J Surg Pathol (2009) 1.13
Reinterpretation of histology of proximal colon polyps called hyperplastic in 2001. World J Gastroenterol (2009) 1.11
Serrated polyps of the large intestine: a molecular study comparing sessile serrated adenomas and hyperplastic polyps. Histopathology (2009) 1.11
Prevalence of colonic neoplasia and advanced lesions in the normal population: a prospective population-based colonoscopy study. Scand J Gastroenterol (2012) 1.11
Small colonic microsatellite unstable adenocarcinomas and high-grade epithelial dysplasias in sessile serrated adenoma polypectomy specimens: a study of eight cases. Am J Clin Pathol (2006) 1.09
Sessile serrated adenomas: demographic, endoscopic and pathological characteristics. World J Gastroenterol (2010) 1.03
Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Patholog Res Int (2011) 1.01
Phenotype and polyp landscape in serrated polyposis syndrome: a series of 100 patients from genetics clinics. Am J Surg Pathol (2012) 1.00
Outcomes of a 5-year follow-up of patients with sessile serrated adenomas. Scand J Gastroenterol (2012) 1.00
Risk factors: Hyperplastic polyposis syndrome and risk of colorectal cancer. Nat Rev Gastroenterol Hepatol (2010) 0.99
Frequent beta-catenin nuclear labeling in sessile serrated polyps of the colorectum with neoplastic potential. Am J Clin Pathol (2008) 0.99
Clinicopathologic and genetic characterization of traditional serrated adenomas of the colon. Am J Clin Pathol (2012) 0.97
Serrated adenoma of the colorectum undergoes a proliferation versus differentiation process: new conceptual interpretation of morphogenesis. Oncology (2008) 0.97
Significance of serrated polyps of the colon. Curr Gastroenterol Rep (2008) 0.96
Hyperplastic polyposis syndrome is associated with cigarette smoking, which may be a modifiable risk factor. Am J Gastroenterol (2010) 0.95
Support for hMLH1 and MGMT silencing as a mechanism of tumorigenesis in the hyperplastic-adenoma-carcinoma (serrated) carcinogenic pathway in the colon. Hum Pathol (2005) 0.95
Observer agreement in the diagnosis of serrated polyps of the large bowel. Histopathology (2009) 0.93
Increased cancer predisposition in family members of colorectal cancer patients harboring the p.V600E BRAF mutation: a population-based study. Cancer Epidemiol Biomarkers Prev (2010) 0.93
Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas. Am J Surg Pathol (2010) 0.93
Hypermethylation of APC promoter 1A is associated with moderate activation of Wnt signalling pathway in a subset of colorectal serrated adenomas. Histopathology (2009) 0.93
Serrated polyps of the colon: how reproducible is their classification? Virchows Arch (2012) 0.91
Does colonoscopy work? J Natl Compr Canc Netw (2010) 0.91
Efficacy and effectiveness of colonoscopy: how do we bridge the gap? Gastrointest Endosc Clin N Am (2010) 0.91
Paneth cell differentiation in colonic epithelial neoplasms: evidence for the role of the Apc/beta-catenin/Tcf pathway. Hum Pathol (2009) 0.91
Sessile serrated adenomas and classical adenomas: an epigenetic perspective on premalignant neoplastic lesions of the gastrointestinal tract. Int J Cancer (2011) 0.91
Update on colonoscopic imaging and projections for the future. Clin Gastroenterol Hepatol (2009) 0.90
Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol (2002) 5.91
High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology (2006) 3.24
Investigating iron deficiency anaemia. Med J Aust (2013) 2.60
Emerging concepts in colorectal neoplasia. Gastroenterology (2002) 2.44
Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. Clin Gastroenterol Hepatol (2010) 2.34
Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut (2010) 2.30
Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation. J Clin Oncol (2004) 2.27
Endoscopic prediction of deep submucosal invasive carcinoma: validation of the narrow-band imaging international colorectal endoscopic (NICE) classification. Gastrointest Endosc (2013) 2.16
Screening for hemochromatosis in asymptomatic subjects with or without a family history. Arch Intern Med (2006) 2.11
Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol (2005) 2.03
Analysis of the association between CIMP and BRAF in colorectal cancer by DNA methylation profiling. PLoS One (2009) 1.90
High-risk human papillomavirus in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev (2010) 1.83
Differentiating adenomas from hyperplastic colorectal polyps: narrow-band imaging can be learned in 20 minutes. Gastrointest Endosc (2010) 1.80
Morphological and molecular heterogeneity within nonmicrosatellite instability-high colorectal cancer. Cancer Res (2002) 1.67
Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat (2013) 1.55
Review of genetic and epigenetic alterations in hepatocarcinogenesis. J Gastroenterol Hepatol (2006) 1.52
Oncogenic PIK3CA mutations in colorectal cancers and polyps. Int J Cancer (2011) 1.40
Measurement Bias of Polyp Size at Colonoscopy. Dis Colon Rectum (2017) 1.38
The impact of videorecording on the quality of colonoscopy performance: a pilot study. Am J Gastroenterol (2010) 1.28
Role of inherited defects of MYH in the development of sporadic colorectal cancer. Genes Chromosomes Cancer (2004) 1.26
Colorectal cancer: molecular features and clinical opportunities. Clin Biochem Rev (2010) 1.19
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer. Clin Cancer Res (2013) 1.17
Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes Chromosomes Cancer (2008) 1.15
Intergroup communication between hospital doctors: implications for quality of patient care. Soc Sci Med (2009) 1.15
Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res (2008) 1.15
The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol (2007) 1.14
Collagenous sprue: a clinicopathologic study of 12 cases. Am J Surg Pathol (2009) 1.13
Identification of genes uniquely involved in frequent microsatellite instability colon carcinogenesis by expression profiling combined with epigenetic scanning. Cancer Res (2004) 1.05
Evolution of colorectal cancer: change of pace and change of direction. J Gastroenterol Hepatol (2002) 1.04
Construct validation of a physical model colonoscopy simulator. Gastrointest Endosc (2012) 1.00
The effects from DNA extraction methods on the evaluation of microbial diversity associated with human colonic tissue. Microb Ecol (2010) 0.97
The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis. Clin Gastroenterol Hepatol (2006) 0.97
Assessing the realism of colonoscopy simulation: the development of an instrument and systematic comparison of 4 simulators. Gastrointest Endosc (2012) 0.96
Repeat participation in colorectal cancer screening utilizing fecal occult blood testing: a community-based project in a rural setting. J Gastroenterol Hepatol (2010) 0.96
The view from two sides: a qualitative study of community and medical perspectives on screening for colorectal cancer using FOBT. Prev Med (2004) 0.96
Genome-wide DNA methylation analysis of formalin-fixed paraffin embedded colorectal cancer tissue. Genes Chromosomes Cancer (2014) 0.95
Hyperplastic polyposis syndrome is associated with cigarette smoking, which may be a modifiable risk factor. Am J Gastroenterol (2010) 0.95
The use of indigocarmine spray increases the colonoscopic detection rate of adenomas. J Gastroenterol (2009) 0.95
Integrated care in the emergency department: a complex adaptive systems perspective. Soc Sci Med (2010) 0.93
Chromosomal instability in BRAF mutant, microsatellite stable colorectal cancers. PLoS One (2012) 0.93
DNA methylation patterns in adenomas from FAP, multiple adenoma and sporadic colorectal carcinoma patients. Int J Cancer (2006) 0.92
A general path for large-scale solubilization of cellular proteins: from membrane receptors to multiprotein complexes. Protein Expr Purif (2012) 0.91
Editorial: Detection targets for colonoscopy: from variable detection to validation. Am J Gastroenterol (2010) 0.90
Relationship of non-polypoid colorectal neoplasms to quality of colonoscopy. Gastrointest Endosc Clin N Am (2010) 0.90
Mutation searching in colorectal cancer studies: experience with a denaturing high-pressure liquid chromatography system for exon-by-exon scanning of tumour suppressor genes. Pathology (2002) 0.90
HLA-DR expression is associated with better prognosis in sporadic Australian clinicopathological Stage C colorectal cancers. Int J Cancer (2009) 0.89
Colonic mucosubmucosal elongated polyp: a clinicopathologic study of 13 cases and review of the literature. Am J Surg Pathol (2011) 0.89
Screening for microsatellite instability identifies frequent 3'-untranslated region mutation of the RB1-inducible coiled-coil 1 gene in colon tumors. PLoS One (2009) 0.88
Determining the frequency of de novo germline mutations in DNA mismatch repair genes. J Med Genet (2011) 0.88
p53 mutation is common in microsatellite stable, BRAF mutant colorectal cancers. Int J Cancer (2011) 0.88
The challenging diagnosis of Cronkhite-Canada syndrome in the upper gastrointestinal tract: a series of 7 cases with clinical follow-up. Am J Surg Pathol (2014) 0.86
SnoN expression is differently regulated in microsatellite unstable compared with microsatellite stable colorectal cancers. BMC Cancer (2006) 0.86
Do serrated neoplasms of the small intestine represent a distinct entity? Pathological findings and molecular alterations in a series of 13 cases. Histopathology (2015) 0.85
Hyperplastic polyp of the duodenum: a report of 9 cases with immunohistochemical and molecular findings. Hum Pathol (2011) 0.85
Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. J Pathol (2003) 0.85
A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. Am J Clin Nutr (2009) 0.84
Reciprocal relationship between methylation status and loss of heterozygosity at the p14(ARF) locus in Australian and South African hepatocellular carcinomas. J Gastroenterol Hepatol (2002) 0.83
Thrombospondin-4 is a putative tumour-suppressor gene in colorectal cancer that exhibits age-related methylation. BMC Cancer (2010) 0.82
Correspondence re: P. Laiho et al., Low-level microsatellite instability in most colorectal carcinomas. Cancer Res., 62: 1166-1170, 2002. Cancer Res (2002) 0.82
DNA methylation in the rectal mucosa is associated with crypt proliferation and fecal short-chain fatty acids. Dig Dis Sci (2010) 0.81
Applying heuristic evaluation to observation chart design to improve the detection of patient deterioration. Appl Ergon (2012) 0.81
Synchronous colorectal cancer: not just bad luck? Gastroenterology (2009) 0.80
Double-balloon colonoscopy carried out by a trainee after incomplete conventional colonoscopy. Dig Endosc (2014) 0.80
Neutrophilic infiltration in gluten-sensitive enteropathy is neither uncommon nor insignificant: assessment of duodenal biopsies from 267 pediatric and adult patients. Am J Surg Pathol (2012) 0.78
Varying etiologies lead to different molecular changes in Australian and South African hepatocellular carcinomas. Int J Oncol (2009) 0.77
Cadherin/catenin complex appears to be intact in hepatocellular carcinomas from Australia and South Africa. J Gastroenterol Hepatol (2004) 0.77
Role of early case detection by screening relatives of patients with HFE-associated hereditary haemochromatosis. Best Pract Res Clin Haematol (2005) 0.76
Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa. Oncol Rep (2007) 0.76
The university of queensland medical leadership program: a case study. Ochsner J (2012) 0.76
Re: Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst (2010) 0.75
Flexible spectral-imaging color enhancement: optimized settings for polyp detection? Gastrointest Endosc (2011) 0.75
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours. Nature (2017) 0.75
Evaluation of a Low-Fidelity Surgical Simulator for Large Loop Excision of the Transformation Zone (LLETZ). Simul Healthc (2017) 0.75